<DOC>
	<DOCNO>NCT00451750</DOCNO>
	<brief_summary>The aim prospective , double-blind , placebo-controlled , randomize study investigate glucocorticoid treatment , combination exposure therapy , help reduce phobic fear patient phobia .</brief_summary>
	<brief_title>Cortisol Treatment Phobias</brief_title>
	<detailed_description />
	<mesh_term>Phobic Disorders</mesh_term>
	<mesh_term>Hydrocortisone 17-butyrate 21-propionate</mesh_term>
	<mesh_term>Cortisol succinate</mesh_term>
	<mesh_term>Hydrocortisone acetate</mesh_term>
	<mesh_term>Hydrocortisone</mesh_term>
	<criteria>Female male patient specific phobia ( fear height ) accord DSMIV criterion . Severe acute chronic somatic disease Psychiatric disorder specific phobia Topic glucocorticoid therapy ( large skin part ) Inhaled glucocorticoid Psychotropic medication Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>January 2010</verification_date>
	<keyword>phobia</keyword>
	<keyword>cortisol</keyword>
	<keyword>memory</keyword>
	<keyword>treatment</keyword>
</DOC>